Navigation Links
Nektar's Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
Date:11/14/2007

Nektar Highlights Innovative New Product Development in the Areas of

Oncology, Anti-Infectives, CNS and Pain Therapies

NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) showcased its two industry-leading Pulmonary and PEGylation technology platforms and the company's innovative proprietary product pipeline at its R&D Day held today at The Palace Hotel in New York.

"Nektar's R&D Day presentation emphasizes our world-class talent and innovative work in the development of breakthrough biopharmaceuticals that leverage our two technology platforms," said Howard W. Robin, President and Chief Executive Officer of Nektar. "Our ground-breaking work in small molecule PEGylation represent significant value for Nektar and promises to result in great improvements to many drugs."

During the event, Nektar scientists and drug development experts highlighted Nektar's pioneering research in the area of small molecule PEGylation and the company's initial market applications of this innovative technology platform in oncology and central nervous system (CNS) therapeutics.

Company Previews NKTR-102 and NKTR-118 Phase 2 Trial Designs

Nektar also previewed its proprietary product clinical development programs, including the Phase 2 clinical trial designs for NKTR-102 (PEG- irinotecan), the company's lead oncolytic candidate under development for the treatment of solid tumors, and NKTR-118 (oral PEG naloxol) for opioid bowel dysfunction.

Nektar Chief Operating Officer and Head of the PEGylation Business Unit, Hoyoung Huh, M.D., Ph.D. said, "Based on positive Phase 1 results with our two lead PEG products that leverage our important research in small molecule PEGy
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...- Welcome to syngo® .plaza(1), the ne...rom Siemens Healthcare. As the first Picture A...iemens where 2D, 3D, and 4D reading come together ...e the way multimodality images are read today. Sie...ientific Assembly and Annual Meeting of the Radiol...
(Date:11/27/2009)...ire-FirstCall/ -- GSI Group Inc. (Pink Sheets: GSI...logy products and semiconductor systems, today ann...reholders has been scheduled for Friday, April 30,...be announced in due course. As previously announc... Stephen Bershad, a holder of greater than ten per...
(Date:11/27/2009)...ire-USNewswire/ -- Preventing disease is the goal ...y year, new vaccines are being added to assist in ...nity for the same period of time? And, if not, whe...munity strong? ,, In this month,s issue of Pe...ediatrics, Michael Pichichero MD, Director of the ...
(Date:11/27/2009)... economic burdens, study predicts , , FR...ople with diabetes in the United States is expecte...edicts. , That would bring the total by 2034 to...om 23.7 million today. , , At the same time, the..., the study also warns, rising from an estimated $...
(Date:11/27/2009)...ve anatomy education apps from Modality and Lippin... learning opportunities for iPhone and iPod touch ...mber 27, 2009 -- Modality, Inc. and Lippincott W... Kluwer Health, today announced the availability o...e. Clemente’s Anatomy, Rohen’s Photogr...
Breaking Medicine News(10 mins):Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
...and MILPITAS, Calif., Sept. 27 ,Flextronics Intern...ation,(NYSE: SLR ) today announced that Flextroni...proved the completion of Flextronics,s proposed,ac...as of June 4, 2007. Flextronics shareholders, at t...
...3,000 leading scientists and clinicians to present...., Sept. 27 - An international,medical meeting wil...m all,fields of science and medicine to Anaheim Oc...sis Conference is an annual,ritual for leading CF ...
...Sept. 27 Bristol-Myers Squibb,(NYSE: BMY ) annou...mpany,s,Research and Development organization as s... and Licensing. He will report to Dr. Elliott Siga...for Bristol-Myers Squibb, as we look to further bu...
...s leading cause of parasitic infections in U.S. , ...have sequenced the genome of the intestinal parasi...,000 reported infections a year in the United Stat...Giardia through contact with infected stool or by ...
...ER, Mass. Several recent research studies publishe...adolescents who see smoking scenes in movies are m...h, public health groups have called for Restricted...ot have the intended effect of putting such movies...
... Real Estate Services Firm Assembles Veteran Healt...dership, CHICAGO, Sept. 27 Alter+Care, one of th...nt firms, has established an,Advisory Board to pro..., announced the Alter+Care Advisory Board,s format...
Other Medicine News:Health News:Flextronics Shareholders and Solectron Stockholders Approve Acquisition 2Health News:Flextronics Shareholders and Solectron Stockholders Approve Acquisition 3Health News:Anaheim to Host World's Largest Cystic Fibrosis Medical Meeting 2Health News:Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing 2Health News:Scientists Map Intestinal Bug's Genome 2Health News:R rating might be unlikely to affect teens exposure to smoking in movies 2Health News:Alter+Care Creates the Advisory Board 2Health News:Alter+Care Creates the Advisory Board 3
(Date:11/29/2009)...Nov. 29 Royal Philips Electronics ...n industry need by showing its portfolio of produc...s 95th annual meeting of the Radiological Society ... from Philips are several advancements and upgrade...iation and streamlining workflow to expand upon cl...
(Date:11/29/2009)... 29 This year at the Radiological ...y and Annual Meeting, FUJIFILM Medical Systems USA...alization space with the introduction of Synapse(T... in image processing by now offering its own advan...phic and cardiovascular applications. The company...
(Date:11/27/2009)...inn, Nov. 27 ACUO TECHNOLOGIES, de...ent software, data migration tools and services, i...t and Trademark Office has approved a patent appli... Computer Network." Acuo Technologies is pleased t...tual property. In general, the granted patent appl...
Breaking Medicine Technology:Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5FUJIFILM Enters Advanced Visualization Market 2FUJIFILM Enters Advanced Visualization Market 3FUJIFILM Enters Advanced Visualization Market 4Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 1EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 3Elbit Imaging Ltd Announces Interest Rate for the Next Interest Period for Series B Notes 13712 1Elbit Imaging Ltd Announces Interest Rate for the Next Interest Period for Series B Notes 13712 2Elbit Imaging Ltd Announces Interest Rate for the Next Interest Period for Series B Notes 13712 3
...uesday, May 13 at 1:00 p.m. EDT ...ENLO PARK, Calif., May 13 /PRNewswire-FirstCall/,-...itive six-month follow-up,data from the CUSTOM III...icacy of the Custom NX(R) drug eluting stent (DES)...y artery disease., The CUSTOM III clinical trial ...
...II Trial Experience Better, Long-Term Clinical Out...ts Treated with TAXUS, ... for the first time today from the SPIRIT III tria...(TM) V Everolimus Eluting Coronary Stent,System, d...nically superior,benefits for patients compared to...
Other Medicine Technology:XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 2XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 3XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 4XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: